<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-07T19:10:33Z</responseDate>
  <request identifier="oai:figshare.com:article/34021491" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34021491</identifier>
        <datestamp>2026-09-29T05:47:58Z</datestamp>
        <setSpec>category_140</setSpec>
        <setSpec>portal_316</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Image 2_Serum free eicosapentaenoic acid-to-arachidonic acid ratio and long-term risk of major adverse cardiovascular events in patients with coronary artery disease.tiff</dc:title>
          <dc:creator>Changguo Ou (25135554)</dc:creator>
          <dc:creator>Wenli Wang (1701169)</dc:creator>
          <dc:creator>Dongliang Liang (9116744)</dc:creator>
          <dc:creator>Jiangxiong Wen (8783708)</dc:creator>
          <dc:creator>Zhiwen Xu (28724)</dc:creator>
          <dc:creator>Yuli Huang (491990)</dc:creator>
          <dc:creator>Jianqiu Liang (25135557)</dc:creator>
          <dc:creator>Jiandi Wu (11900273)</dc:creator>
          <dc:subject>Cardiology</dc:subject>
          <dc:subject>coronary artery disease</dc:subject>
          <dc:subject>free EPA/AA ratio</dc:subject>
          <dc:subject>major adverse cardiovascular events</dc:subject>
          <dc:subject>non-esterified fatty acids</dc:subject>
          <dc:subject>prognosis</dc:subject>
          <dc:description>Background&lt;p&gt;The eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio reflects the balance between n-3 and n-6 polyunsaturated fatty acids. We examined the association between the serum free (non-esterified) EPA/AA ratio and long-term major adverse cardiovascular events (MACE) in patients with angiographically confirmed coronary artery disease (CAD).&lt;/p&gt;Methods&lt;p&gt;This single-center retrospective cohort study included 308 patients with CAD. Serum free fatty acids were quantified by LC-MS/MS, and the free EPA/AA ratio was evaluated as the primary fatty-acid biomarker. Cox proportional hazards models were used to estimate hazard ratios (HRs), and principal component analysis (PCA) was used to explore fatty-acid patterns.&lt;/p&gt;Results&lt;p&gt;During a median follow-up of 48.7 months, 201 first MACE events occurred. In the fully adjusted primary analysis, each 1-SD increase in the free EPA/AA ratio was associated with a lower risk of MACE (HR = 0.82, 95% CI 0.70–0.96, P = 0.011; FDR-adjusted P = 0.049). The association was attenuated after additional adjustment for analytical batch (HR = 0.92, 95% CI 0.77–1.10, P = 0.375) and in a Cox model stratified by batch (HR = 0.92, 95% CI 0.77–1.11, P = 0.398).&lt;/p&gt;Conclusions&lt;p&gt;A higher serum free EPA/AA ratio was associated with a lower risk of MACE in the primary multivariable analysis, but the association was attenuated in additional sensitivity analyses. These findings should be interpreted cautiously and require validation in independent cohorts.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T05:47:58Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.3389/fcvm.2026.1944383.s003</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/Image_2_Serum_free_eicosapentaenoic_acid-to-arachidonic_acid_ratio_and_long-term_risk_of_major_adverse_cardiovascular_events_in_patients_with_coronary_artery_disease_tiff/34021491</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
